Bruker Corp at Citi Healthcare & Medtech Conference Transcript
All right. We can look to get started. So thanks, everyone, for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. Happy to have Gerald Herman, CFO of Bruker with us for this session. Gerald, thanks for being here.
Questions & Answers
Maybe we can start, you guys reported the quarter pretty recently here, strong results, really nice guide for '23. Maybe just talk to the quarter quickly, kind of the moving pieces and then we can kind of get into orders in '23 and kind of move on from there.
Sure. Well, thanks for inviting us. Happy to be here. It's always a pleasure to be in New York. I guess I'd say relative to the fourth quarter, a pretty solid performance across almost all of our end markets. We put up quite strong order bookings performance, in particular, in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |